1
Total investments
0
Early stage
0
Mid stage
0
Late stage
3y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Member & Investor
Aug 2023
Lifespan.io is a non profit education and advocacy organization. We promote advancement of biomedical technologies which can increase healthy human lifespan and seek to raise awareness regarding related societal benefits.
Our website also enables the public to interact with and crowdfund longevity research initiatives.
Experience · 4 entries
All (4)
Investments (1)
Founder (3)
2023
Member & Investor
Aug 2023
Lifespan.io is a non profit education and advocacy organization. We promote advancement of biomedical technologies which can increase healthy human lifespan and seek to raise awareness regarding related societal benefits.
Our website also enables the public to interact with and crowdfund longevity research initiatives.
Founder & Principal
Jan 2023
BIO Consulting Group is a specialized consultancy firm that offers a wide range of services tailored to meet the unique needs of clients in the biotechnology, synthetic biology, pharmaceutical, and life sciences industries. Our team of experienced professionals leverages their in-depth knowledge and expertise to provide innovative solutions that drive success for our clients.
2019
CEO & Founder
Jan 2019
SYTE.bio is a Synthetic Biology Start-Up company developing precision DNA & RNA-based therapeutics and vaccines. The company has been incorporated as a Delaware C Corp in 2021 (SYTE.bio, Inc), and has labs & offices in Argentinas headquarter, that has been operating since 2017. SYTE.bio is pioneering the development of life-changing treatments for severe diseases and vaccines to treat and prevent diseases at the molecular and cellular level using engineered DNA, improving life through innovation.
SYTE.bio’s powerful redosable DNA & RNA delivery platforms will unleash the potential of personalized genetic medicine in multiple potential applications, such as Gene Therapy (Oncology, Monogenic Diseases, Cardiovascular Diseases, Vaccines, Orphan Diseases), Cell Therapy (CAR-T Therapy, Induced Pluripotent Stem Cells (iPSC)) and Gene Editing (CRISPR/Cas, TALEN, ZFN).
2017
V
VIROgene
Founder & CEO
Oct 2017